GRA5

GRA5 is a Toxoplasma gondii dense granule protein that is secreted into the parasitophorous vacuole and functions as a structural component of the vacuolar and cyst membranes across the parasite life cycle (PMID:8515776, PMID:8344403, PMID:10198072). It is initially secreted as a soluble form into the PV lumen and subsequently inserts into the parasitophorous vacuole membrane (PVM) as a transmembrane protein with its N-terminus facing the host cytoplasm and its C-terminus in the vacuole lumen; deletion within its single hydrophobic transmembrane domain abolishes PVM association without disrupting granule packaging or soluble secretion (PMID:10198072). Its N-terminal ectodomain is required both to prevent premature membrane integration inside the parasite and to direct correct post-secretory sorting and insertion into the vacuolar membrane, a soluble trafficking behavior that is parasite-specific, since in mammalian cells GRA5 inserts directly into the plasma membrane as a type I integral membrane protein (PMID:18631244). Within the parasite and PV soluble fraction GRA5 assembles into high-molecular-weight oligomeric complexes with GRA3, GRA6, and GRA7, retaining only an association with GRA7 after PVM insertion (PMID:17959262). During bradyzoite differentiation GRA5 transitions to the cyst membrane and cyst wall, where it is required for normal cyst wall maturation and, in the ME49 strain, for tissue cyst formation in vivo (PMID:8344403, PMID:31941814, PMID:37426671). GRA5 also contributes to immune evasion by suppressing MHC-I presentation of PV-localized antigens to CD8+ T cells (PMID:31555296), and its soluble N-terminal domain modulates dendritic cell migration via CCR7 (PMID:23033174). GRA5 is dispensable for the tachyzoite lytic cycle in vitro (PMID:11522359).

1. 1993 High

   Establishing GRA5's primary structure and localization defined it as a PVM-associated dense granule protein with a signal peptide and a transmembrane domain, framing all later trafficking work.

   Evidence cDNA/genomic cloning, peptide microsequencing of native antigen, and ultrastructural immunolocalization in T. gondii

   PMID:8515776

   Open questions at the time

   • Did not resolve membrane topology or the mechanism of PVM insertion
   • No functional role established
2. 1993 High

   Demonstrating that GRA5 sorts selectively to the cyst-wall delimiting membrane while GRA2 goes to the ground substance showed that dense granule contents are differentially targeted after exocytosis.

   Evidence Immunogold electron microscopy with monoclonal antibodies on tachyzoite and bradyzoite stages

   PMID:8344403

   Open questions at the time

   • Sorting signal responsible for selective targeting not identified
   • Functional consequence of cyst membrane localization not tested
3. 1996 High

   Identifying shared cis-acting promoter motifs explained how GRA5 is co-regulated with other dense granule genes at the transcriptional level.

   Evidence Transient CAT reporter transformation with promoter deletion and site-directed mutagenesis in T. gondii

   PMID:8858595

   Open questions at the time

   • Trans-acting factors binding the motif not identified
   • Stage-specific regulation not addressed
4. 1997 Medium

   Finding GRA5 to be the only dense granule protein secreted into the sporozoite's first PV distinguished its early exocytosis behavior from other GRAs.

   Evidence Immunofluorescence and immunoelectron microscopy of sporozoite-infected host cells with stage-specific antibodies

   PMID:9353039

   Open questions at the time

   • Single method (immunolocalization) and single lab
   • Mechanistic basis for selective sporozoite secretion unknown
5. 1999 High

   Resolving that GRA5 is secreted soluble and then inserts into the PVM as a transmembrane protein with defined topology established its post-secretory membrane integration mechanism.

   Evidence Biochemical fractionation, protease-protection topology assays, and transmembrane deletion mutagenesis in T. gondii

   PMID:10198072

   Open questions at the time

   • Machinery mediating post-secretory insertion not identified
   • Signal preventing premature integration not yet mapped
6. 2001 Medium

   Showing gra5 deletion does not impair tachyzoite growth established that GRA5 is dispensable for the asexual lytic cycle, redirecting attention to non-growth roles.

   Evidence Genetic knockout of gra5 with phenotypic analysis of tachyzoite growth in T. gondii

   PMID:11522359

   Open questions at the time

   • Negative in vitro phenotype leaves in vivo and stage-specific roles untested
   • Single lab
7. 2007 High

   Defining GRA5's oligomeric partners and their change upon membrane insertion revealed that GRA5 acts within multiprotein GRA complexes whose composition is remodeled at the PVM.

   Evidence Affinity purification of tagged GRA5 from null-background parasites, chromatography, and mass spectrometry in T. gondii

   PMID:17959262

   Open questions at the time

   • Stoichiometry and functional role of the complexes not established
   • Whether GRA7 association is direct not shown
8. 2008 High

   Heterologous expression showed GRA5's soluble trafficking is parasite-specific and mapped the N-terminal ectodomain as the determinant preventing premature integration and directing PVM insertion.

   Evidence Heterologous expression of GRA5 and truncation mutants in mammalian cells with topology and fractionation assays

   PMID:18631244

   Open questions at the time

   • Parasite-specific factor recognizing the ectodomain not identified
   • Molecular mechanism of insertion still unresolved
9. 2012 Medium

   Demonstrating that the soluble GRA5 N-terminal domain drives CCR7-dependent dendritic cell migration identified an immunomodulatory function for its ectodomain independent of membrane insertion.

   Evidence In vitro DC migration and macropinocytosis assays and human skin Langerhans cell depletion using recombinant protein and peptide

   PMID:23033174

   Open questions at the time

   • Host receptor engaged by the peptide not identified
   • In vivo relevance during infection not established
10. 2019 Medium

    Knockout comparisons showed GRA5 among several GRAs suppresses MHC-I presentation of PV antigens to CD8+ T cells, linking GRA5 to immune evasion.

    Evidence CD8+ T cell antigen presentation assays with Δgra mutant parasites in macrophages and dendritic cells

    PMID:31555296

    Open questions at the time

    • Molecular mechanism of MHC-I suppression not defined
    • Individual contribution of GRA5 versus other GRAs not isolated
11. 2020 High

    Tracking GRA5 through bradyzoite differentiation and knockout analysis established that PVM-localized GRA5 is required for normal cyst wall maturation.

    Evidence Live imaging/IFA time course, saponin permeabilization, and Δgra5 cyst wall protein accumulation analysis in T. gondii

    PMID:31941814

    Open questions at the time

    • Mechanism by which GRA5 promotes cyst wall protein accumulation unknown
    • Direct interactions within the cyst wall not defined
12. 2023 Medium

    In vivo knockout in ME49 showed GRA5 is required for tissue cyst formation and that Δgra5 confers cross-strain protective immunity, establishing GRA5's role in chronic-stage biology and vaccine potential.

    Evidence CRISPR gra5 knockout in ME49, mouse infection/challenge, cyst burden, and immune phenotyping

    PMID:37426671

    Open questions at the time

    • Mechanistic basis for cyst formation failure not defined
    • Whether protection generalizes beyond mouse model unknown

• The parasite-specific machinery that keeps GRA5 soluble in the PV and mediates its post-secretory insertion into the PVM and cyst membrane remains unidentified.
• No trans-acting factor recognizing the N-terminal ectodomain identified
• Mechanism connecting PVM insertion to cyst wall maturation unresolved
• Molecular basis of MHC-I suppression unknown